Vigil Neuroscience, Inc. 3 SEC Filings

Filed On	Filing
20 Mar 2024	Form 3: Kaufmann Petra, Chief Medical Officer No securities owned
07 Aug 2023	Form 3: Silber Christopher, Chief Medical Officer No securities owned
09 May 2023	Form 3: Budd Haeberlein Samantha L., Director No securities owned
27 Feb 2023	Form 3: Gray David L. F., Chief Science Officer No securities owned
28 Jul 2022	Form 3: Bruhn Suzanne Louise, Director No securities owned
20 Apr 2022	Form 3: Verni Christopher, General Counsel No securities owned
20 Apr 2022	Form 3: Thistle Mary, Director No securities owned
06 Jan 2022	Form 3: Vitorovic Stefan, Director
06 Jan 2022	Form 3: Amgen Inc, 10% owner
06 Jan 2022	Form 3: Thackaberry Evan, SVP, Head of Early Development
06 Jan 2022	Form 3: Koenig Gerhard, Director
06 Jan 2022	Form 3: Blanchard Cheryl R, Director
06 Jan 2022	Form 3: Magovcevic-Liebisch Ivana, Director Holds 198,687 shares of Common Stock
06 Jan 2022	Form 3: Thorp Clay, Director
06 Jan 2022	Form 3: Papapetropoulos Spyridon, Chief Medical Officer
06 Jan 2022	Form 3: Booth Bruce, Director Holds 1,442,376 shares of Common Stock
06 Jan 2022	Form 3: Ziolkowski Jennifer Lynn, Chief Financial Officer
06 Jan 2022	Form 3: Atlas Venture Fund XII, L.p., 10% owner and 5 others Holds 1,442,376 shares of Common Stock
06 Jan 2022	Form 3: Vida Ventures Gp III, L.l.c., 10% owner and 2 others
06 Jan 2022	Form 3: Gandhi Shaan-Chirag C, Director No securities owned

Comments